| ISIN | CH0389550945 |
|---|---|
| Valor Number | 38955094 |
| Bloomberg Global ID | UBSSPLW SW |
| Fund Name | UBS (CH) Investment Fund - Equities Switzerland Leader Index A-acc |
| Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Asset Management Switzerland AG, Zurich |
| Representative in Switzerland | |
| Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
| Asset Class | Bonds |
| EFC Category | Equity Switzerland |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | ... |
| Peculiarities |
| Current Price * | 166.38 CHF | 15.12.2025 |
|---|---|---|
| Previous Price * | 164.64 CHF | 12.12.2025 |
| 52 Week High * | 166.38 CHF | 15.12.2025 |
| 52 Week Low * | 135.84 CHF | 09.04.2025 |
| NAV * | 166.38 CHF | 15.12.2025 |
| Issue Price * | 166.38 CHF | 15.12.2025 |
| Redemption Price * | 166.38 CHF | 15.12.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 2,198,297,522 | |
| Unit/Share Assets *** | 132,666,713 | |
| Trading Information SIX | ||
| YTD Performance | +13.02% |
31.12.2024 - 15.12.2025
31.12.2024 15.12.2025 |
|---|---|---|
| 1 month | +3.50% |
17.11.2025 - 15.12.2025
17.11.2025 15.12.2025 |
| 3 months | +5.14% |
15.09.2025 - 15.12.2025
15.09.2025 15.12.2025 |
| 6 months | +6.79% |
16.06.2025 - 15.12.2025
16.06.2025 15.12.2025 |
| 1 year | +11.77% |
16.12.2024 - 15.12.2025
16.12.2024 15.12.2025 |
| 2 years | +24.03% |
15.12.2023 - 15.12.2025
15.12.2023 15.12.2025 |
| 3 years | +37.97% |
15.12.2022 - 15.12.2025
15.12.2022 15.12.2025 |
| 5 years | +47.87% |
15.12.2020 - 15.12.2025
15.12.2020 15.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 9.99% | |
|---|---|---|
| Nestle SA | 9.46% | |
| Novartis AG Registered Shares | 8.96% | |
| UBS Group AG Registered Shares | 8.38% | |
| Compagnie Financiere Richemont SA Class A | 4.99% | |
| ABB Ltd | 4.44% | |
| Zurich Insurance Group AG | 4.43% | |
| Swiss Re AG | 4.40% | |
| Holcim Ltd | 4.22% | |
| Lonza Group Ltd | 4.09% | |
| Last data update | 30.11.2025 | |
| TER | 0.19% |
|---|---|
| TER date | 30.09.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.30% |
| Ongoing Charges *** | 0.22% |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |